Enveric Biosciences Inc (FRA:SLZA)

€ 0.4755 -0.004 (-0.83%) Market Cap: 4.13 Mil Enterprise Value: -2.40 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 54/100

Enveric Biosciences Inc at H.C. Wainwright Neuropsychiatry Virtual Conference Transcript
Jun 26, 2023
Enveric Biosciences Inc Annual Shareholders Meeting Transcript
Oct 28, 2022
Ameri Holdings Inc to Discuss Merger with Jay Pharma Inc Conference Call Transcript
Jan 16, 2020

Ameri Holdings Inc to Discuss Merger with Jay Pharma Inc Conference Call Transcript

Jan 16, 2020 / 09:15PM GMT

Release Date Price: €436

Transcript

Operator

Good day, and welcome to AMERI Conference Call to discuss merger with Jay Pharma. (Operator Instructions)

On today's call, we have Barry Kostiner, Chief Financial Officer of AMERI Holdings; and Dave Johnson, Chairman and CEO-elect of Jay Pharma. Please note, this event is being recorded.

I would now like to turn the conference over to Barry Kostiner.

Barry Kostiner

AMERI Holdings, Inc. - CFO

Thank you, operator. Good afternoon, everyone. I am Barry Kostiner, Chief Financial Officer of AMERI. Thank you for joining us to discuss the amalgamation agreement between AMERI and Jay Pharma.

Please note that this call is being recorded and that the press release regarding the amalgamation agreement is available on the websites of both AMERI and Jay Pharma. I refer you to the legal disclosures contained in today's press release that also govern today's call. A replay of this call will be available until the merger is closed.

I will start with a brief recap of the merger we announced this past Monday. Dave Johnson, Chairman and CEO

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.